Compare StocksABBV vs HSIC

AbbVie Inc. (ABBV) vs Henry Schein, Inc. (HSIC): Which Is the Better Buy in 2026?

As of 2026-09-17, ABBV is overvalued at $262, with a DCF intrinsic value of $184 and a margin of safety of -43%. HSIC is fairly valued at $84, with an intrinsic value of $85 and a margin of safety of 1%. Of the two, HSIC has the wider margin of safety.

ABBV
AbbVie Inc.
$262.43
VS
HSIC
Henry Schein, Inc.
$84.29

Rewards

ABBV
  • AbbVie Inc. has maintained ROIC above 10% for 4 consecutive years, suggesting solid business economics.
  • Gross margin of 72.8% indicates strong pricing power — typical of businesses with significant intellectual property or brand strength.
  • AbbVie Inc. scores 82/100 on the Economic Moat Score (Wide Moat), with reinvestment efficiency as the strongest competitive dimension.
HSIC
  • Share count has been reduced by 12% over the past 4 years through buybacks, increasing each share's claim on earnings.

Risks

ABBV
  • Buybacks have been poorly timed — 3 out of 4 years involved repurchases at relatively expensive valuations.
  • Insiders have sold $8.2M worth of stock in the past 3 months — significant insider liquidation.
  • Free cash flow has declined at a 9.8% CAGR over the past 4 years — a concerning trend.
HSIC

    Key Valuation Metrics

    Learn more →
    ABBV
    HSIC
    Valuation
    $16.87B
    Free Cash Flow
    $446.00M
    3.64%
    FCF Yield
    4.75%
    74.13
    Trailing P/E
    24.57
    16.13
    Forward P/E
    14.05
    Quality & Moat
    28.73%
    ROIC
    7.24%
    N/A
    ROE
    8.85%
    72.79%
    Gross Margin
    31.32%
    0.54
    PEG Ratio
    1.77
    Balance Sheet Safety
    N/A
    Net Debt / Equity
    0.77
    N/A
    Interest Coverage
    N/A
    2.09
    Net Debt / EBITDA
    3.39
    2.64%
    Dividend Yield
    0.00%
    ABBV: 6Ties: 1HSIC: 3
    ABBVHSIC

    Historical Fundamentals

    Learn more →
    ABBV

    Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

    HSIC

    Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

    Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

    $1 Retained Earnings Test

    Learn more →
    ABBV
    N/A
    Net losses over 3 years — test not applicable
    Company had negative cumulative retained earnings
    Σ Retained
    $-19.85B
    Δ Market Cap
    +$118.02B
    Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
    > $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer
    HSIC
    $-1.48
    created per $1 retained over 3 years
    Market Cap Declined
    Σ Retained
    $1.20B
    Δ Market Cap
    $-1.78B
    Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
    > $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

    Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
    > $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

    Discounted Cash Flow (DCF) Analysis

    Learn more →
    ABBV
    42.6% Overvalued
    Price is 42.6% above estimated fair value
    Current Price: $262.43
    Fair Value: $183.97
    Strongly undervalued
    Undervalued
    Fairly valued
    Overvalued
    Strongly overvalued
    HSIC
    0.7% Margin of Safety
    Price is 0.7% below estimated fair value
    Current Price: $84.29
    Fair Value: $84.85
    Strongly undervalued
    Undervalued
    Fairly valued
    Overvalued
    Strongly overvalued

    Reverse DCF — Market-Implied Growth

    Learn more →
    ABBV

    What growth rate is the market pricing in at $262?

    +19.5%
    Market-Implied Owner Earnings Growth
    Standard FCF implies +13.8%

    The market implies +19.5% Owner Earnings growth, above historical trends.

    Standard FCF implies a demanding +13.8%, reflecting heavy growth investment.

    HSIC

    What growth rate is the market pricing in at $84?

    +11.7%
    Market-Implied Owner Earnings Growth
    Standard FCF implies +12.9%

    The market implies +11.7% Owner Earnings growth, above historical trends.

    Standard FCF implies a demanding +12.9%, reflecting heavy growth investment.

    Economic Moat Score

    Learn more →
    ABBV
    82/100
    Wide Moat
    70+ Wide · 40-69 Narrow · <40 None

    Wide moat with strength across all dimensions. Reinvestment Efficiency is the standout factor.

    Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.
    HSIC
    57/100
    Narrow Moat
    70+ Wide · 40-69 Narrow · <40 None

    Narrow moat with revenue predictability as the key competitive advantage. Improving roic consistency would strengthen the moat.

    Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.

    Forensic Accounting

    Learn more →
    ABBV
    -2.86
    Unlikely Manipulator
    Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

    M-Score Trend

    Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.
    HSIC
    -2.53
    Unlikely Manipulator
    Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

    M-Score Trend

    Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

    Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

    Ownership Breakdown

    Learn more →
    ABBV
    Insiders 0.1%Institutions 77.4%Retail & Other 22.5%
    No. of Institutional Holders5,262
    High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.
    HSIC
    Insiders 0.8%Institutions 112.3%
    No. of Institutional Holders788
    High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.

    High insider ownership aligns management incentives with shareholders. Institutional concentration can indicate smart-money conviction but also crowding risk.

    Insider Buying Activity

    Learn more →
    ABBV
    0
    Buys (3M)
    0
    Buys (12M)
    No open market insider purchases found.
    Open market purchases · includes direct & indirect ownership · excludes option exercises
    HSIC
    0
    Buys (3M)
    1
    Buys (12M)
    Total value (12M): $691,900
    DANIEL WILLIAM K
    Director
    $691,900
    @ $69.19 · 2026-05-11
    DANIEL WILLIAM K
    Director
    $670,800
    @ $67.08 · 2025-08-07
    Open market purchases · includes direct & indirect ownership · excludes option exercises

    Open market purchases · includes direct & indirect ownership · excludes option exercises.

    Insider Selling Activity

    Learn more →
    ABBV
    1
    Sells (3M)
    4
    Sells (12M)
    Total value (12M): $18.92M
    DONOGHOE NICHOLAS
    Officer
    $8.18M
    @ $250.00 · 2026-08-14
    PURDUE DAVID RYAN
    Officer
    $1.22M
    @ $233.56 · 2026-03-04
    SIATIS PERRY C.
    General Counsel
    $4.38M
    @ $234.39 · 2026-03-02
    SIATIS PERRY C.
    General Counsel
    $5.15M
    @ $230.00 · 2026-02-25
    SALEKI-GERHARDT AZITA
    Chief Operating Officer
    $8.41M
    @ $198.42 · 2025-08-12
    DONOGHOE NICHOLAS
    Officer
    $2.64M
    @ $198.51 · 2025-08-05
    STEWART JEFFREY RYAN
    Officer
    $12.36M
    @ $210.08 · 2025-03-31
    REENTS SCOTT T.
    Chief Financial Officer
    $3.75M
    @ $212.34 · 2025-03-14
    RICHMOND TIMOTHY J
    Officer
    $4.47M
    @ $210.45 · 2025-03-03
    SIATIS PERRY C.
    General Counsel
    $5.82M
    @ $208.69 · 2025-03-03
    GONZALEZ RICHARD A
    Director
    $20.26M
    @ $205.45 · 2025-03-03
    RICHMOND TIMOTHY J
    Officer
    $6.07M
    @ $202.90 · 2025-02-26
    BUCKBEE KEVIN K
    Officer
    $3.85M
    @ $203.41 · 2025-02-26
    SIATIS PERRY C.
    General Counsel
    $1.14M
    @ $197.90 · 2025-02-20
    BUCKBEE KEVIN K
    Officer
    $310,032
    @ $172.24 · 2024-12-16
    Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives
    HSIC
    0
    Sells (3M)
    4
    Sells (12M)
    Total value (12M): $1.03M
    POPECK THOMAS C
    Officer
    $98,630
    @ $72.79 · 2026-03-19
    KUEHN KURT P
    Director
    $224,565
    @ $78.96 · 2026-03-10
    LASKAWY PHILIP A
    Director
    $228,544
    @ $80.36 · 2026-03-05
    MLOTEK MARK E
    Officer
    $478,740
    @ $80.80 · 2026-03-04
    CONNETT BRADFORD C
    Officer
    $287,161
    @ $71.15 · 2025-03-19
    LASKAWY PHILIP A
    Director
    $184,999
    @ $71.04 · 2025-03-19
    KUEHN KURT P
    Director
    $199,396
    @ $71.55 · 2025-03-05
    ETTINGER MICHAEL S.
    Chief Operating Officer
    $918,000
    @ $75.00 · 2024-11-18
    Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives

    Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives.

    🎭 Mr. Market's Mood

    Learn more →
    ABBV
    FearGreed
    😏Greed(70/100)

    "Market is optimistic — be cautious and ensure you have a margin of safety"

    Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.
    HSIC
    FearGreed
    😐Neutral(50/100)

    "Market is pricing this stock without strong emotion in either direction"

    Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

    Composite sentiment score based on market signals. Inspired by Buffett’s "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

    ⚖️ Buffett Signal

    Learn more →
    ABBV
    Awaiting DCF Data

    The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

    DCF Margin of Safety: N/AMr. Market's Mood: Greed (70)
    HSIC
    Awaiting DCF Data

    The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

    DCF Margin of Safety: N/AMr. Market's Mood: Neutral (50)
    View ABBV Full AnalysisView HSIC Full Analysis

    Frequently Asked Questions: ABBV vs HSIC

    Is AbbVie Inc. or Henry Schein, Inc. more undervalued in 2026?

    Based on our discounted cash flow model, HSIC trades at a 0.7% margin of safety (intrinsic value $85 vs. price $84), compared to ABBV's -42.6% margin of safety (intrinsic $184 vs. $262).

    Which stock has a wider economic moat, AbbVie Inc. or Henry Schein, Inc.?

    ABBV scores 82/100 (Wide moat), while HSIC scores 57/100 (Narrow moat). The moat score measures competitive advantage durability across ROIC consistency, margin stability, revenue predictability, and reinvestment efficiency.

    Is AbbVie Inc. in financial distress?

    ABBV's Altman Z-Score of 2.4 places it in the Grey zone, signaling elevated bankruptcy risk. HSIC scores 2.8 (Grey zone). The Altman Z-Score is a five-factor model that predicts insolvency within two years; scores below 1.81 indicate significant distress.

    Which company has better free cash flow, AbbVie Inc. or Henry Schein, Inc.?

    Henry Schein, Inc. (HSIC) generates a 4.7% free cash flow yield, compared to AbbVie Inc.'s 3.6%. A higher FCF yield means the business converts more of its market value into cash that can be returned to shareholders or reinvested.

    Which stock has higher return on invested capital, AbbVie Inc. or Henry Schein, Inc.?

    ABBV earns 28.7% ROIC versus HSIC's 7.2%. A higher ROIC means the company generates more profit per dollar of capital employed, a hallmark of durable competitive advantage in Buffett-style analysis.